Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Technology entities : Eli lilly and company save search
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Kv1.3 Inhibitor for Immunological Diseases Including IBD and AD
Published: 2024-01-30 (Crawled : 09:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.11%
H: 0.17%
C: -0.11%
technology potential
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
Published: 2024-01-19 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.15%
H: 1.16%
C: 0.99%
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: 2.36%
H: 2.76%
C: -4.15%
presentation technology platform
Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.62%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.94%
H: 2.55%
C: 2.55%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.52%
H: 0.04%
C: 0.04%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.87%
H: 0.73%
C: 0.28%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.16%
H: 0.7%
C: 0.57%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -4.06%
H: 1.9%
C: 0.96%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
expected reach global dna medical technology market
Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II Grant to Advance Development of Novel Platelet Preservation Technology
Published: 2023-09-28 (Crawled : 11:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.22%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.28%
H: 0.07%
C: -1.25%
grant technology
ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
Published: 2023-03-29 (Crawled : 12:20) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.4%
H: 0.23%
C: -0.92%
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: -10.34%
H: 1.56%
C: -21.5%
axiomer pipeline technology platform
Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology
Published: 2023-03-14 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.14%
H: 1.0%
C: 0.93%
technology therapeutics
InvisiShield Technologies Announces Scientific Advisory Board
Published: 2023-01-11 (Crawled : 14:20) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.45%
H: 2.09%
C: 1.71%
technology
Lilly and ProQR to Expand RNA Editing CollaborationNew agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology
Published: 2022-12-22 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.19%
H: 0.66%
C: -0.55%
PRQR | News | $1.965 5.65% 5.34% 130K
|
Health Technology
|
| O: 64.85%
H: 13.97%
C: -0.74%
axiomer technology agreement
Triastek announces research collaboration with Lilly to explore the application of 3D printing technology in oral delivery of drugs
Published: 2022-07-14 (Crawled : 02:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -1.53%
H: 3.22%
C: 2.94%
research collaboration application technology
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.98%
H: 0.66%
C: -0.87%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: -0.57%
H: 0.96%
C: -0.24%
trials research technology trial
Immunomodulators Market: Trends & Opportunities | Global Industry Analysis [2021-2031] The demand in the global immunomodulators market is expected to increment at a potent CAGR during the forecast period of 2017 to 2025, which can be attributed to a number of key factors, such as increasing adoption of monoclonal antibodies, presence of strong pipeline portfolio, strong adoption of TNF-alpha inhibitors and B-cell inhibitors, advancements in the diagnostic tools, and the development of novel therapies using innovative technologies. In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market | Forecast [2021-2031] In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels. Isothermal Nucleic Acid Amplification Technology Market Analysis and Opportunity Assessment up to 2031 Wilmington, Delaware, United States: Surge in the prevalence of different infectious diseases globally is projected to create substantial opportunities for sales growth in the isothermal nucleic acid amplification technology market during the forecast period of 2021 to 2031. Medical Sensors Market to Gain US$ 32.15 Bn by 2028, Growing Awareness about Health and Fitness to Drive Global Market Wilmington, Delaware, United States: According to the report, the global medical sensors market was valued at US$ 15.23 Bn in 2020 and is projected to expand at a CAGR of 9.9% from 2021 to 2028. Oral Care Products Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The global oral care products market is anticipated to witness moderate growth during the forecast period between 2021 and 2031. Pharmacovigilance Market: Size | Share | Trends | Global Industry Outlook, 2031 Pharmacovigilance is a process refereeing to the detection, collection, prevention, and monitoring of negative effects that may occur because of the use of pharmaceutical products and other drugs. Stoma Care Market Insights by Size, Status and Forecast 2031 Wilmington, Delaware, United States: Because of the high frequency of bladder cancer and colorectal cancer, growing number of activities to develop awareness about stoma, rising demand for stoma care and accessories, and technological developments is expected to drive global stoma care market in the near future. Structural Biology and Molecular Modeling Techniques Market | Global Industry Analysis [2021-2031] The global structural biology and molecular modeling techniques market is a novel conception in the global healthcare sector and has already made key contributions in obtaining remedies to a number of diseases. Addiction Treatment Market to Generate US$ 12 Bn by 2030 | Growth & Key Business Strategies Wilmington, Delaware, United States: According to the report, the global addiction treatment market was valued at ~US$ 6 Bn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Antibacterial Drugs Market: Increasing Prevalence of Infectious Diseases to Drive the Market Wilmington, Delaware, United States: Bacterial drugs are the substances that may destroy or constrain the microorganism growth such as bacteria. Antifungal Drugs Market Demand and Global Competitive Insights 2031 Wilmington, Delaware, United States: The growing threat of fungal infections among a considerable chunk of the global populace is estimated to bring considerable growth prospects for the antifungal drugs market during the forecast period of 2021-2031. Bioimpendance Analysers Market Segmentation and Analysis Report, 2031 Wilmington, Delaware, United States: The demand in the global bioimpendance analysers market is surging owing to high growth potential amongst emerging economies such as Brazil and India. Bioinformatics Services Market Worldwide Major Trend Outlook 2021 to 2031 Wilmington, Delaware, United States: The essential types of services provided by the vendors and players functional within the global bioinformatics services market include data analysis, gene expression, sequencing, database management, and discovery, among others. Biomedical Refrigerators and Freezers Market: Trends, Regional Outlook and Competitive Analysis [2021-2031]
Published: 2022-06-17 (Crawled : 08:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.74%
H: 0.52%
C: -3.23%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.35%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
sales treatment care trends brazil services antibacterial growing diagnostic health expected infections technology diagnostics potential molecular cancer growth negative market bladder fungal infection in vitro
Capsida Biotherapeutics Poised to Capitalize on Industry-leading Gene Therapy Technology With New CEO, CSO, and CTO
Published: 2021-12-07 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.84%
H: 0.49%
C: 0.36%
STIM | $3.8 -0.78% -0.79% 49K
|
Health Technology
|
| O: 1.7%
H: 5.97%
C: 3.34%
gene therapy new ceo ceo technology therapeutics therapy iot
Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Published: 2021-11-16 (Crawled : 15:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
QTRX | $15.84 0.32% 0.32% 360K
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: -1.52%
disease alzheimer clinical trials trials technology research trial conference alzheimer’s alzheimer's disease alzheimer's
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
Published: 2021-08-06 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
QTRX | $15.84 0.32% 0.32% 360K
|
Health Technology
|
| O: -2.26%
H: 2.64%
C: -5.91%
disease alzheimer technology research conference alzheimer’s alzheimer's disease alzheimer's
The Galien Foundation Debuts 2021 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology" and "Best Digital Health Solution" Categories
Published: 2021-08-06 (Crawled : 04:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.54%
H: 0.18%
C: -1.21%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
GKOS | $96.5 1.44% 0.0% 700K
|
Health Technology
|
| O: -4.43%
H: 5.13%
C: 4.76%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.13%
H: 0.06%
C: -0.02%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.1%
H: 1.97%
C: 1.29%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: -0.34%
H: 0.04%
C: -6.6%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -1.14%
H: 2.45%
C: 1.76%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.23%
H: 0.14%
C: -0.52%
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: -1.82%
H: 4.94%
C: 4.33%
biotech technology iot
The Galien Foundation Debuts 2021 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Agent," "Best Medical Technology" and "Best Digital Health Solution" Categories
Published: 2021-07-20 (Crawled : 14:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.83%
H: 0.53%
C: -0.06%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.23%
H: 0.87%
C: 0.31%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.01%
H: 2.34%
C: 0.93%
GKOS | $96.5 1.44% 0.0% 700K
|
Health Technology
|
| O: -10.48%
H: 0.13%
C: -4.92%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.37%
H: 1.17%
C: 0.01%
BSX | $67.33 -0.13% -0.31% 7M
|
Health Technology
|
| O: 0.22%
H: 4.07%
C: 3.56%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.11%
H: 1.89%
C: 0.43%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.29%
H: 1.02%
C: 0.78%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.52%
H: 0.92%
C: -0.18%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.22%
H: 3.66%
C: 3.66%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 0.13%
H: 2.21%
C: -0.39%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.13%
H: 2.12%
C: 1.23%
EIGR | $1.725 -1.45% 140K
|
Health Technology
|
| O: 0.25%
H: 3.02%
C: 2.77%
biotech technology iot
Lilly Announces Acquisition of Protomer Technologies
Published: 2021-07-14 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.21%
H: 0.61%
C: 0.24%
acquisition technology
Synaffix Licenses its Award-Winning ADC Technology in Deal Adding a New ADC to Innovent’s Pipeline
Published: 2021-06-29 (Crawled : 13:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.01%
H: 1.38%
C: 0.49%
license technology
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
Published: 2021-06-29 (Crawled : 00:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.01%
H: 1.38%
C: 0.49%
license technology
Global $69.5 Billion Clinical Trials Market to 2028: Increasing R&D Promoting Outsourcing & Adoption of New Technology in Clinical Research
Published: 2021-06-08 (Crawled : 18:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.49%
H: 0.05%
C: -0.16%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.36%
H: 0.25%
C: -0.46%
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: 0.5%
H: 0.77%
C: -0.63%
new technology clinical trials research technology trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.